At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada.
| Autor: | Schleihauf E; Public Health Agency of Canada, Halifax, Nova Scotia, Canada., Crabtree K; Nova Scotia Prescription Monitoring Program, Dartmouth, Nova Scotia, Canada., Dohoo C; Public Health Agency of Canada, Ottawa, Ontario, Canada., Fleming S; Nova Scotia Department of Health and Wellness, Halifax, Nova Scotia, Canada., McPeake H; Nova Scotia Prescription Monitoring Program, Dartmouth, Nova Scotia, Canada., Bowes M; Nova Scotia Medical Examiner Service, Dartmouth, Nova Scotia, Canada. |
|---|---|
| Jazyk: | English; French |
| Zdroj: | Health promotion and chronic disease prevention in Canada : research, policy and practice [Health Promot Chronic Dis Prev Can] 2018 Sep; Vol. 38 (9), pp. 334-338. |
| DOI: | 10.24095/hpcdp.38.9.05 |
| Abstrakt: | Timely public health surveillance is required to understand trends in opioid use and harms. Here, opioid dispensing data from the Nova Scotia Prescription Monitoring Program are presented alongside fatality data from the Nova Scotia Medical Examiner Service. Concurrent monitoring of trends in these data sources is essential to detect population-level effects (whether intended or unintended) of interventions related to opioid prescribing. Competing Interests: All authors have no conflicts of interest to disclose. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|